Stock Research for SLP

Current Price

$16.5500


Latest Update: 2018-02-23 16:00:00

High
$ 16.6000
Low
$ 16.5500
Close
$ 16.6000
Volume
2540
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

SLP Stock Chart & Research Data

The SLP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SLP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SLP Due diligence Resources & Stock Charts

The SLP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SLP Detailed Price Forecast - CNN Money CNN View SLP Detailed Summary - Google Finance
Yahoo View SLP Detailed Summary - Yahoo! Finance Zacks View SLP Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View SLP Trends & Analysis - Trade-Ideas Barrons View SLP Major Holders - Barrons
NASDAQ View SLP Call Transcripts - NASDAQ Seeking View SLP Breaking News & Analysis - Seeking Alpha
Spotlight View SLP Annual Report - CompanySpotlight.com OTC Report View SLP OTC Short Report - OTCShortReport.com
TradeKing View SLP Fundamentals - TradeKing Charts View SLP SEC Filings - Bar Chart
WSJ View Historical Prices for SLP - The WSJ Morningstar View Performance/Total Return for SLP - Morningstar
MarketWatch View the Analyst Estimates for SLP - MarketWatch CNBC View the Earnings History for SLP - CNBC
StockMarketWatch View the SLP Earnings - StockMarketWatch MacroAxis View SLP Buy or Sell Recommendations - MacroAxis
Bullish View the SLP Bullish Patterns - American Bulls Short Pains View SLP Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View SLP Stock Mentions - StockTwits PennyStocks View SLP Stock Mentions - PennyStockTweets
Twitter View SLP Stock Mentions - Twitter Invest Hub View SLP Investment Forum News - Investor Hub
Yahoo View SLP Stock Mentions - Yahoo! Message Board Seeking Alpha View SLP Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for SLP - SECform4.com Insider Cow View Insider Transactions for SLP - Insider Cow
CNBC View SLP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SLP - OTC Markets
Yahoo View Insider Transactions for SLP - Yahoo! Finance NASDAQ View Institutional Holdings for SLP - NASDAQ


Stock Charts

FinViz View SLP Stock Insight & Charts - FinViz.com StockCharts View SLP Investment Charts - StockCharts.com
BarChart View SLP Stock Overview & Charts - BarChart Trading View View SLP User Generated Charts - Trading View


Latest Financial News for SLP

Simulations Plus Launches Version 2.0 of PKPlus™
Posted on Thursday February 01, 2018

Simulations Plus, Inc. , the premier provider of simulation and modeling software and consulting services for pharmaceutical development from earliest discovery through all phases of clinical trials, today announced the launch of version 2.0 of PKPlus, a major update to its software for analysis of preclinical and clinical trial data.


Simulations Plus Subsidiary Cognigen Releases KIWI Version 2
Posted on Wednesday January 24, 2018

Cognigen Corporation, a Simulations Plus company and a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that it has released Version 2 of its KIWI™ Pharmacometric Communication and Collaboration Platform.


EX-Dividend Schedule: Simulations Plus Has a Dividend Yield of 1.47%; Will Trade Ex-Dividend on January 25, 2018
Posted on Wednesday January 24, 2018

LONDON, UK / ACCESSWIRE / January 24, 2018 / Active-Investors has a free review on Simulations Plus, Inc. (NASDAQ: SLP ) following the Company's announcement that it will begin trading ex-dividend on January ...


Should You Be Tempted To Sell Simulations Plus Inc (NASDAQ:SLP) Because Of Its PE Ratio?
Posted on Sunday January 21, 2018

Simulations Plus Inc (NASDAQ:SLP) is currently trading at a trailing P/E of 45.8x, which is higher than the industry average of 34.6x. Although some investors may jump to the conclusionRead More...


Simulations Plus to Acquire DILIsym Services, Inc.
Business Wire (press release) - May 1, 2017
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has entered into a Stock Purchase Agreement (the ...

DILIsym Services Inc., a Simulations Plus Company, Releases DILIsym® Version 7A
Business Wire (press release) - Jan 11, 2018
DILIsym Services, Inc. was founded in 2015 in Research Triangle Park, North Carolina, and is the leading provider of drug-induced liver injury simulation software and related consulting services to the pharmaceutical industry. The company spun out of ...

Simulations Plus, Inc. (SLP) Ex-Dividend Date Scheduled for November 10, 2017
Nasdaq - Nov 9, 2017
Simulations Plus, Inc. ( SLP ) will begin trading ex-dividend on November 10, 2017. A cash dividend payment of $0.06 per share is scheduled to be paid on November 20, 2017.

Simulations Plus Closes Acquisition of DILIsym Services, Inc.
Business Wire (press release) - Jun 1, 2017
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that the Stock Purchase Agreement (the “Agreement”) with ...

Enter a stock symbol to view the stock details.